Quantcast
Last updated on April 16, 2014 at 7:57 EDT

Latest Bacillus Calmette-Guérin Stories

2014-03-24 12:29:41

Aeras releases TB Crisis Tracker on World TB Day ROCKVILLE, Md., March 24, 2014 /PRNewswire/ -- The tuberculosis epidemic continues to impact pockets of the U.S. population, according to a data visualization tool developed by the nonprofit biotech, Aeras. Launched on World TB Day, Aeras's TB Crisis Tracker illustrates how the TB epidemic continues to impact the U.S. "TB's impact in the U.S. is but a fraction of what it once was, but the Aeras TB Crisis Tracker starkly...

2014-03-20 04:21:53

BEIJING and HILDEN, Germany, March 20, 2014 /PRNewswire/ -- - QuantiFERON-TB, the leading modern test for accurate diagnosis of latent tuberculosis infections, continues to grow rapidly around the world - Commercial launch of QuantiFERON-TB in China, where latent TB affects an estimated 41% of population, will support nationwide efforts to control TB - QIAGEN marks World TB Day 2014 on March 24 with QuantiFERON-TB...

Tuberculosis Vaccine Cure For MS
2013-12-05 11:34:05

Brett Smith for redOrbit.com - Your Universe Online A new preliminary study from a team of Italian researchers has found that a vaccine used to thwart tuberculosis outside the US could be used to treat multiple sclerosis (MS). In the study, which was published in the journal Neurology, scientists found people who had early symptoms of MS and MRI scans pointing to the development of the neurological condition benefited from receiving an injection of Bacille Calmette-Guérin, which is...

Tuberculosis Vaccine Shows Promising Results
2013-10-03 04:39:56

redOrbit Staff & Wire Reports - Your Universe Online Canadian researchers have developed a new tuberculosis vaccine that could boost or perhaps replace the only existing way to immunize against the infection. The researchers say the new vaccine is an important breakthrough because the current tuberculosis vaccine is not effective enough to curb the TB epidemic in some parts of the world. "We are the first to have developed such a vaccine for tuberculosis," said Dr. Fiona Smaill,...

2013-08-16 10:38:06

A new study has calculated the average cost per case of TB in the EU. The findings suggest the economic burden of TB far outweighs the costs of investing in more effective vaccines. The research, published online today (16 August 2013), in the European Respiratory Journal, is the first study to estimate the costs of the disease in recent years. Researchers used a systematic review of literature and institutional websites for the 27 EU member states to summarise economic data on the...

Tuberculosis Vaccine Fails Infant Trial
2013-02-04 14:42:30

[ Watch the Video: Discussing New Tuberculosis Vaccine Trials ] Lee Rannals for redOrbit.com - Your Universe Online A new vaccine considered to be the most advanced for tuberculosis (TB) among more than a dozen now in trials has failed its study. Researchers said they were disappointed by the results of the study, which showed that the vaccine offered little to no protection at all from TB. Nearly 3,000 babies in South Africa took part in the study, all of whom had already been...

2012-10-09 23:20:19

Phase IIb Proof of Concept Trial Planned for Kenya, India and South Africa ROCKVILLE, Md., Oct. 10, 2012 /PRNewswire-USNewswire/ -- Aeras announces that it has signed an agreement with GlaxoSmithKline Vaccines, S.A. (GSK) to jointly advance the clinical development of an investigational tuberculosis (TB) vaccine containing GSK's proprietary M72 antigen and AS01(E)(*) adjuvant. This novel research and resource-sharing agreement between the largest non-profit TB vaccine biotech and one...

2012-08-29 07:57:54

Cases of one of the world's deadliest diseases–tuberculosis–are rising at an alarming rate, despite widespread vaccination. Reasons for the ineffectiveness of the vaccine, especially in regions where this infectious disease is endemic, as well as arguments for replacing the existing vaccine with novel synthetic vaccines, are presented in a review published online August 28th in Trends in Molecular Medicine. "Tuberculosis is a global health threat, and it is a highly...

2012-08-22 06:24:25

Phase I study in Lenexa, KS, of novel vaccine targeting TB virulence and latency ROCKVILLE, Md. and SEATTLE, Aug. 22, 2012 /PRNewswire-USNewswire/ -- Aeras and the Infectious Disease Research Institute (IDRI) announce today the start of the first clinical trial of IDRI's novel tuberculosis vaccine candidate, ID93 + GLA-SE. The Phase I clinical trial will assess the safety, tolerability and immunogenicity of the vaccine candidate in 60 healthy adult volunteers. The study will be...

Tuberculosis Vaccine Possibly Reverse Diabetes
2012-08-10 09:09:08

Connie K. Ho for redOrbit.com — Your Universe Online Researchers recently discovered that a tuberculosis vaccine could decrease autoimmunity and boost insulin production in patients who have long-term Type 1 diabetes. The vaccine has been utilized for the past 90 years and scientists believe that it could help eliminate the necessity of having insulin injections for patients with Type 1 diabetes. With Type 1 diabetes, patients normally need to inject insulin on a daily basis so...


Latest Bacillus Calmette-Guérin Reference Libraries

45_255d6ba67dfe6f32b9c7c31f338bf912
2011-04-18 22:11:24

Mycobacterium bovis is a slow-growing, aerobic bacterium and the causative agent of tuberculosis in cattle. Similar to M. tuberculosis, M. bovis can jump the species barrier and cause tuberculosis in humans. It is estimated that M. bovis was responsible for more losses among farm animals than all other diseases combined in the first half of the 20th century. Infection happens after bacterium is ingested. It is generally transmitted to humans via infected milk. Actual human infections are...

More Articles (1 articles) »